Conditioning regimen: Patients who are intolerable to conventional conditioning regimen due to either higher age (55>
Sponsors
Division of Hematology, Saitama Medical Center, Jichi Medical University
Conditions
High-risk advanced hematological disease(leukemia and malignant lymphoma in non-remission, MDS with more than 20% of blast, and relapsed disease after allogeneic transplantation)Standard-risk advanced hematological disease(leukemia and malignant lymphoma in remission, MDS, IMF, and SAA)advanced hematological malignancy
Unknown Phase
HLA-mismatched allogeneic hematopoietic stem cell transplantation for advanced hematological malignancy using low-dose alemtuzumab
Active, not recruitingJPRN-UMIN000007913
Start: 2012-04-01Target: 14Updated: 2026-06-29
HLA-mismatched allogeneic hematopoietic stem cell transplantation for standard-risk advanced hematological disease using low-dose alemtuzumab
Active, not recruitingJPRN-UMIN000018283
Start: 2015-07-14Target: 23Updated: 2026-06-29
HLA-mismatched allogeneic hematopoietic stem cell transplantation for high-risk advanced hematological disease with the adjustments of immunosuppressants and low-dose alemtuzumab.
Active, not recruitingJPRN-UMIN000018298
Start: 2015-07-14Target: 28Updated: 2026-06-29